Life science companies developing bird flu vaccines are gaining attention as the avian influenza subtype H5N1 becomes an ...

Receiving an electronic reminder about influenza vaccination appeared to decrease COVID vaccination rates. Further study of ...

The new agreement comes at a time when GSK and CureVac have been at risk of falling behind in mRNA vaccines for respiratory diseases, with combined flu/COVID-19 candidates from Moderna and Pfizer ...

Vaccine hesitancy cost lives during Covid-19—but countries in Central and Eastern Europe can learn from Britain’s, and from ...

New findings from a recent white paper highlight the economic and healthcare burden posed by Respiratory Syncytial Virus (RSV ...

Clare Bryant, Professor of Innate Immunity, is a molecular detective. She looks at how bodies defend themselves and tries to ...

Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...

CureVac and partner GSK are, meanwhile, also developing an mRNA-based flu vaccine, but are a little further back in development, as their shot is in phase 1 testing. Influenza causes 140,000 to ...

The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...

The other brands containing thiomersal are Fluarix by GlaxoSmithKline, Influvac by Solvay Health Care and Agrippal by Wyeth. Mercury-free flu jab brands available on the NHS are Begrivac from ...